Learn more about what IQT and our portfolio companies are doing to support COVID-19 response efforts. B.Next, IQT’s biodefense initiative, has been preparing tools and resources to support the medical community as well as decision makers, technologists, and other stakeholders to help understand, manage, and respond to COVID-19. Learn more
Insights & Access
IQT invests in commercially-focused, venture capital-backed startups to identify and adapt “ready-soon” technology – off-the-shelf products that can be modified, tested, and delivered for use within 6 to 36 months. This ready-soon focus means IQT finds and delivers critical, innovative technology quickly and cost effectively.
IQT focuses on mission-critical areas such as:
How We Work
IQT identifies startups with potential for high impact on national security and works closely with them to deliver new capabilities that our government partners need to boost their technological edge.
IQT accelerates the introduction of cutting-edge technologies that protect and preserve national security. Our success is measured by the value our investments deliver to the government’s ability to further national security capabilities.
IQT works side-by-side with the venture capital community to identify cutting-edge technology that has the potential for commercial success, but more importantly, the potential for high national security impact.